Companies

Specialized in Joint Health therapeutic area, the company is fully integrated from the origin of the active ingredient to the medicinal product and patient and has an extensive molecular, medical and market knowledge.

Established since 1975, Bioiberica is a privately owned company which has built up a strong research, marketing and manufacturing foundation; the company currently employs over 380 members of staff and has 8 manufacturing plants located in Spain (4), USA, Poland, Italy and Brazil.

Constantly researching in chondroprotection, in terms of current developments Bioiberica has 15 projects of basic research, 3 molecules in pre-clincal status and 2 projects of clinical research under development.

Based on an holistic aproach to osteoarthritis, the company offers a wide range of chondroprotective drugs and dietary supplements as well as DNA chips and biomarkers for Osteoarthritis.

Bioiberica is looking for strategic partners that distribute its range of products on a local/regional basis.

Bioiberica Joint Care has developed three product lines, Bio-Active, Nutri-Joint and Finished Products to cover all market segments, offering a complete Joint Health Care Portfolio based on science, quality and safety. The leading pharmaceutical, veterinarian and nutritional supplement companies worldwide rely on Bio-Active ingredients, taking advantage of Bioiberica's experience.

At Bioiberica, they produce and market ingredients for the manufacture of feeds of high nutritional quality and veterinary products for animal nutrition. The company's products are designed to improve the nutrition and health of the digestive and immune systems, improving disease immunity and overall animal health. Furthermore, the excellent palatability and digestibility of our products improves feed consumption, thereby promoting animal growth.

Today's farm production is subject to numerous stress-causing factors: extreme weather conditions (cold, heat, drought, torrential rain, etc.), lack of water, salt content, as well as plagues, diseases and many others. These adverse factors have a negative effect on the quality and quantity of yields. The company's products work naturally on the plants' innate mechanisms to overcome these stress factors.

The company is also involved in GMP manufacturing of heparins and derivatives and four manufacturing plants give us a global commitment as the main European supplier of heparin. This business unit has a portfolio that includes natural active ingredients with antithrombotic activity that are used in the development of pharmaceutical products such as low-molecular-weight heparins and topical antithrombotic agents.